Sage Journals: Discover world-class research

Retricted access

Research article

First published 2011-03

Successful Treatment with GEMOX in Patient with Metastatic Pancreatic Adenosquamous Carcinoma

Gaetano Aurilio, Teresa Macarulla, Javier Francisco Ramos [...]

Tumori Journal

Open access

Research article

First published 2009

Adjuvant Gemcitabine-Oxaliplatin (GeMOX) after Curative Surgery in High-risk Patients with Cholangiocarcinoma

Bernard Paule, Paola Andreani, Marie-Pierre Bralet [...]

Clinical Medicine Insights: Oncology

Retricted access

Research article

First published 2025

Descriptive analysis of the efficacity of R-GEMOX /R-IE/R-CEPP in patients with relapsed/refractory (R/R) transplant-ineligible diffuse large B-cell lymphoma (DLBCL)

Baptiste Fulbert, Théo Vincent, Justine Clarenne [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2023

Efficacy and safety of a triple combination of atezolizumab,bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter,single-arm,retrospective study

Kang Wang, Zong-Han Liu, Hong-Ming Yu [...]

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2023-4

The physical exam’s role in determining dose-limiting toxicity prior to immunochemotherapy administration in lymphoma

John S. Runge, Anna B. Brown, Tycel J. Phillips [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2025-1

A Cost-Effectiveness Analysis of Diffuse Large B-Cell Lymphoma Treatment Pathways in the United States

Anik R. Patel, Bradley Kievit, Ken Hasegawa [...]

MDM Policy & Practice

Retricted access

Case report

First published 2022-6

Severe Generalized Weakness,Paraplegia following administration of Oxaliplatin in a patient with refractory T-cell non-Hodgkin lymphoma: A case report

B. Zarei, M. Moeini Nodeh, O. Arasteh

Journal of Oncology Pharmacy Practice

Search results

Successful Treatment with GEMOX in Patient with Metastatic Pancreatic Adenosquamous Carcinoma

Adjuvant Gemcitabine-Oxaliplatin (GeMOX) after Curative Surgery in High-risk Patients with Cholangiocarcinoma

Descriptive analysis of the efficacity of R-GEMOX /R-IE/R-CEPP in patients with relapsed/refractory (R/R) transplant-ineligible diffuse large B-cell lymphoma (DLBCL)

Efficacy and safety of a triple combination of atezolizumab,bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter,single-arm,retrospective study

The physical exam’s role in determining dose-limiting toxicity prior to immunochemotherapy administration in lymphoma

A Cost-Effectiveness Analysis of Diffuse Large B-Cell Lymphoma Treatment Pathways in the United States

Severe Generalized Weakness,Paraplegia following administration of Oxaliplatin in a patient with refractory T-cell non-Hodgkin lymphoma: A case report